Top Markets
Coin of the day
Kailera Therapeutics, Inc. Kailera Therapeutics, Inc.

Kailera Therapeutics, Inc.

KLRA
株式のランク #5958
Kailera Therapeutics is a biopharmaceutical company currently advancing through... Kailera Therapeutics is a biopharmaceutical company currently advancing through its clinical development stage, dedicated to cultivating a varied portfolio of cutting-edge treatments. These therapeutics are specifically engineered to tackle obesity and its associated metabolic disorders. The company distinguishes itself through its focus on innovative methodologies, offering both injectable and orally administered formulations for sustainable weight management. Its most advanced candidate is a groundbreaking dual-action gut hormone receptor agonist, which has reported encouraging outcomes in its initial clinical investigations.
株価
$18.55
時価総額
$2.40B
変化(1日)
0.60%
変化(1年)
-
US
取引 Kailera Therapeutics, Inc. (KLRA)

カテゴリー

Kailera Therapeutics, Inc.(KLRA)の配当利回りの履歴
Kailera Therapeutics, Inc.(銘柄コード: KLRA)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Kailera Therapeutics, Inc.(KLRA)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)